Confirmed Speakers

Stylianos Antonarakis, Hôpitaux Universitaires de Genève, Switzerland

René Bernards, The Netherlands Cancer Institute, The Netherlands

Peer Bork, EMBL Heidelberg, Germany

Anne-Lise Børresen-Dale, Oslo University Hospital, Norway

Michael Boutros, DKFZ Heidelberg, Germany

Barrett Bready, NABsys, Inc., USA

Anne Cambon-Thomsen, UMR Inserm/University Paul Sabatier, France

Kelly A. Frazer, Moores UCSD Cancer Center, USA

Robert Gentleman, Gentech International Ltd, United Kingdom

Hank Greely, Stanford Law School, USA

Leroy Hood, Institute for Systems Biology, USA

Tim Hubbard, Wellcome Trust Sanger Institute, United Kingdom

Wolfgang Huber, EMBL Heidelberg, Germany

Olli Kallioniemi, Institute for Molecular Medicine Finland, Finland

Jan Korbel, EMBL Heidelberg, Germany

Peter Lichter, German Cancer Research Centre, Germany

Joseph Nadeau, Institute for Systems Biology, USA

John Overrington, EMBL-EBI, United Kingdom

Kári Stefánsson, deCODE genetics, Iceland

Lars Steinmetz, EMBL Heidelberg, Germany

Greg Tyrelle, Complete Genomics Inc., The Netherlands

Cornelia van Duijn, Erasmus University MC, The Netherlands

Christoph von Kalle, NCT Heidelberg, Germany